Evolve BioSystems is an infant microbiome company dedicated to developing the next generation of products to establish, restore and maintain a healthy gut microbiome. The foundation is working with Evolve to further develop and apply its lead probiotic, Evivo, to Read More
Program Areas: Enteric & Diarrheal Diseases
Press Release: Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
June 12, 2018 DAVIS, Calif., June 13, 2018 /PRNewswire/ —Â Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation, Read More
Synlogic
Synlogic is a start-up company in Boston, developing a first-in-class synthetic biology platform for genetically engineering bacteria of the microbiome for delivery of therapeutics to the gut, initially focused on metabolic imbalance and inflammatory disease.
Al Jazeera: Zambia cholera crisis: ‘Burying people by the hundreds’
January 14, 2018 Zambia’s government says it will ease some of the emergency measures it introduced to stamp out a cholera outbreak that has killed at least 72 people. Al Jazeera looks at how health workers are delivering new solutions Read More
Stanford Social Innovation Review: Making Markets Work for the Poor
The Stanford Social Innovation Review explores how the Bill & Melinda Gates Foundation uses strategic investments for social impact. Read the full report here. Chapters: Philanthropy’s New Tools for Innovation and Impact Leveraging the Balance Sheet Neglected No More Unintended Read More